SCOPEof Pain: An Evaluation of an Opioid Risk Evaluation and Mitigation Strategy Continuing Education Program
| Autor: | Julie L White, Lara Zisblatt, Daniel P. Alford, Sophie Peloquin, Ilana Hardesty, Sean M. Hayes, Pamela Ng |
|---|---|
| Rok vydání: | 2015 |
| Předmět: |
medicine.medical_specialty
Scope (project management) business.industry Chronic pain Alternative medicine MEDLINE Continuing education General Medicine medicine.disease Risk evaluation Anesthesiology and Pain Medicine Nursing Opioid Family medicine medicine Neurology (clinical) Risk assessment business medicine.drug |
| Zdroj: | Pain Medicine. |
| ISSN: | 1526-2375 |
| Popis: | Objective Due to the high prevalence of prescription opioid misuse, the US Food and Drug Administration (FDA) mandated a Risk Evaluation and Mitigation Strategy (REMS) requiring manufacturers of extended-release/long-acting (ER/LA) opioid analgesics to fund continuing education based on a FDA Blueprint. This article describes the Safe and Competent Opioid Prescribing Education (SCOPE of Pain) program, an ER/LA opioid analgesic REMS program, and its impact on clinician knowledge, confidence, attitudes, and self-reported clinical practice. Method Participants of the 3-h SCOPE of Pain training completed pre-, immediate post- and 2-month post-assessments. Subjects The primary target group (n = 2,850), and a subset (n = 476) who completed a 2-month post-assessment, consisted of clinicians licensed to prescribe ER/LA opioid analgesics, who care for patients with chronic pain and who completed the 3-h training between February 28, 2013 and June 13, 2014. Results Immediately post-program, there was a significant increase in correct responses to knowledge questions (60% to 84%, P ≤ 0.02) and 87% of participants planned to make practice changes. At 2-months post-program, there continued to be a significant increase in correct responses to knowledge questions (60% to 69%, P ≤ 0.03) and 67% reported increased confidence in applying safe opioid prescribing care and 86% reported implementing practice changes. There was also an improvement in alignment of desired attitudes toward safe opioid prescribing. Conclusions The SCOPE of Pain program improved knowledge, attitudes, confidence, and self-reported clinical practice in safe opioid prescribing. This national REMS program holds potential to improve the safe use of opioids for the treatment of chronic pain. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text